← Leaderboards
Elizabeth Wagner
Johns Hopkins University
$9,262,640
Attributed
$10,912,720
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$10,912,720 · 7
By mechanism
R01$8,165,919 · 4
P01$2,746,801 · 3
Top collaborators
- Gregory M Lanza5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Steven R Kleeberger$929,417
- David B Pearse$4,668,571
- Wayne Mitzner$20,452,046
- Steven Piantadosi$42,538,163
- Charles M Balch$719,652
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungInflammatoryAngiogenesisEdemaPerfusionBlood FlowChronicCellsAsthmaBlood VesselsAnimal ModelPathologyCytokineInflammationBaseIschemiaLeft Pulmonary ArteryPermeabilityGrowthGrowth FactorLung DiseasesMolecularLigationPhysiology
Grant awards (26)
Theranostic Approach to Asthma Using Anti-Angiogenic Nanomedicine$673,514
R01 · FY2016 · HL
Theranostic Approach to Asthma Using Anti-Angiogenic Nanomedicine$663,410
R01 · FY2015 · HL
Theranostic Approach to Asthma Using Anti-Angiogenic Nanomedicine$660,044
R01 · FY2014 · HL
Theranostic Approach to Asthma Using Anti-Angiogenic Nanomedicine$641,184
R01 · FY2013 · HL
Theranostic Approach to Asthma Using Anti-Angiogenic Nanomedicine$662,009
R01 · FY2012 · HL
Bronchial Vascular Proliferation and Function$405,900
R01 · FY2012 · HL · contact PI
CD4+t-cells control angiogenesis in chronic lung ischemia$464,253
P01 · FY2011 · HL · contact PI
Bronchial Vascular Proliferation and Function$410,000
R01 · FY2011 · HL · contact PI
Angiogenesis in the Lung$412,586
R01 · FY2010 · HL · contact PI
Bronchial Vascular Proliferation and Function$410,000
R01 · FY2010 · HL · contact PI
Effects of Distension on the Airway Vasculature$427,382
P01 · FY2009 · HL · contact PI
Angiogenesis in the Lung$418,520
R01 · FY2009 · HL · contact PI
Bronchial Vascular Proliferation and Function$410,000
R01 · FY2009 · HL · contact PI
Effects of Distension on the Airway Vasculature$407,022
P01 · FY2008 · HL · contact PI
Effects of Distension on the Airway Vasculature$403,115
P01 · FY2007 · HL · contact PI
Angiogenesis in the Lung$387,569
R01 · FY2007 · HL · contact PI
Angiogenesis in the Lung$399,144
R01 · FY2006 · HL · contact PI
Effects of Distension on the Airway Vasculature$376,274
P01 · FY2006 · HL · contact PI
Angiogenesis in the Lung$408,750
R01 · FY2005 · HL
Effects of Distension on the Airway Vasculature$363,431
P01 · FY2005 · HL
Angiogenesis in the Lung$408,750
R01 · FY2004 · HL
Angiogenesis in the Lung$396,050
R01 · FY2003 · HL
AIRWAY PARTICLE CLEARANCE--ROLE OF BRONCHIAL CIRCULATION$202,189
R01 · FY2001 · HL
BRONCHIAL VASCULAR CONTROL OF AIRWAY INFLAMMATION$0
P01 · FY2001 · HL
BRONCHIAL VASCULAR CONTROL OF AIRWAY INFLAMMATION$305,324
P01 · FY2000 · HL
AIRWAY PARTICLE CLEARANCE--ROLE OF BRONCHIAL CIRCULATION$196,300
R01 · FY2000 · HL